Alfred Mann has completed the car wreck of Afrezza. Big Pharma was unable to get a deal from a 88 years old Mann. So the fact they can't buy the next best thing is to see it never sees the light of day. For a couple million to the right FDA person. They will just issue another crl request a little more data. Alfred has weakened mankind thru his Personelly dulited mnkd stock. When he could have issued 200,000,000 total to raise real cash to bring Afrezza to market. I wanted Afrezza to make it for diabetics and retail shareholders. But now we get neither.